Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.

Human mini-brains (MB) are cerebral organoids that recapitulate in part the complexity of the human brain in a unique three-dimensional in vitro model, yielding discrete brain regions reminiscent of the cerebral cortex. Specific proteins linked to neurodegenerative disorders are physiologically expr...

Full description

Bibliographic Details
Main Authors: Serena Pavoni, Rafika Jarray, Ferid Nassor, Anne-Cécile Guyot, Steve Cottin, Jessica Rontard, Jacqueline Mikol, Aloïse Mabondzo, Jean-Philippe Deslys, Frank Yates
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0209150
_version_ 1818938408303591424
author Serena Pavoni
Rafika Jarray
Ferid Nassor
Anne-Cécile Guyot
Steve Cottin
Jessica Rontard
Jacqueline Mikol
Aloïse Mabondzo
Jean-Philippe Deslys
Frank Yates
author_facet Serena Pavoni
Rafika Jarray
Ferid Nassor
Anne-Cécile Guyot
Steve Cottin
Jessica Rontard
Jacqueline Mikol
Aloïse Mabondzo
Jean-Philippe Deslys
Frank Yates
author_sort Serena Pavoni
collection DOAJ
description Human mini-brains (MB) are cerebral organoids that recapitulate in part the complexity of the human brain in a unique three-dimensional in vitro model, yielding discrete brain regions reminiscent of the cerebral cortex. Specific proteins linked to neurodegenerative disorders are physiologically expressed in MBs, such as APP-derived amyloids (Aβ), whose physiological and pathological roles and interactions with other proteins are not well established in humans. Here, we demonstrate that neuroectodermal organoids can be used to study the Aβ accumulation implicated in Alzheimer's disease (AD). To enhance the process of protein secretion and accumulation, we adopted a chemical strategy of induction to modulate post-translational pathways of APP using an Amyloid-β Forty-Two Inducer named Aftin-5. Secreted, soluble Aβ fragment concentrations were analyzed in MB-conditioned media. An increase in the Aβ42 fragment secretion was observed as was an increased Aβ42/Aβ40 ratio after drug treatment, which is consistent with the pathological-like phenotypes described in vivo in transgenic animal models and in vitro in induced pluripotent stem cell-derived neural cultures obtained from AD patients. Notably in this context we observe time-dependent Aβ accumulation, which differs from protein accumulation occurring after treatment. We show that mini-brains obtained from a non-AD control cell line are responsive to chemical compound induction, producing a shift of physiological Aβ concentrations, suggesting that this model can be used to identify environmental agents that may initiate the cascade of events ultimately leading to sporadic AD. Increases in both Aβ oligomers and their target, the cellular prion protein (PrPC), support the possibility of using MBs to further understand the pathophysiological role that underlies their interaction in a human model. Finally, the potential application of MBs for modeling age-associated phenotypes and the study of neurological disorders is confirmed.
first_indexed 2024-12-20T06:07:23Z
format Article
id doaj.art-42b286926f5245ecbb4e3f4752714fc2
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T06:07:23Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-42b286926f5245ecbb4e3f4752714fc22022-12-21T19:50:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011312e020915010.1371/journal.pone.0209150Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.Serena PavoniRafika JarrayFerid NassorAnne-Cécile GuyotSteve CottinJessica RontardJacqueline MikolAloïse MabondzoJean-Philippe DeslysFrank YatesHuman mini-brains (MB) are cerebral organoids that recapitulate in part the complexity of the human brain in a unique three-dimensional in vitro model, yielding discrete brain regions reminiscent of the cerebral cortex. Specific proteins linked to neurodegenerative disorders are physiologically expressed in MBs, such as APP-derived amyloids (Aβ), whose physiological and pathological roles and interactions with other proteins are not well established in humans. Here, we demonstrate that neuroectodermal organoids can be used to study the Aβ accumulation implicated in Alzheimer's disease (AD). To enhance the process of protein secretion and accumulation, we adopted a chemical strategy of induction to modulate post-translational pathways of APP using an Amyloid-β Forty-Two Inducer named Aftin-5. Secreted, soluble Aβ fragment concentrations were analyzed in MB-conditioned media. An increase in the Aβ42 fragment secretion was observed as was an increased Aβ42/Aβ40 ratio after drug treatment, which is consistent with the pathological-like phenotypes described in vivo in transgenic animal models and in vitro in induced pluripotent stem cell-derived neural cultures obtained from AD patients. Notably in this context we observe time-dependent Aβ accumulation, which differs from protein accumulation occurring after treatment. We show that mini-brains obtained from a non-AD control cell line are responsive to chemical compound induction, producing a shift of physiological Aβ concentrations, suggesting that this model can be used to identify environmental agents that may initiate the cascade of events ultimately leading to sporadic AD. Increases in both Aβ oligomers and their target, the cellular prion protein (PrPC), support the possibility of using MBs to further understand the pathophysiological role that underlies their interaction in a human model. Finally, the potential application of MBs for modeling age-associated phenotypes and the study of neurological disorders is confirmed.https://doi.org/10.1371/journal.pone.0209150
spellingShingle Serena Pavoni
Rafika Jarray
Ferid Nassor
Anne-Cécile Guyot
Steve Cottin
Jessica Rontard
Jacqueline Mikol
Aloïse Mabondzo
Jean-Philippe Deslys
Frank Yates
Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
PLoS ONE
title Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
title_full Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
title_fullStr Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
title_full_unstemmed Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
title_short Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.
title_sort small molecule induction of aβ 42 peptide production in human cerebral organoids to model alzheimer s disease associated phenotypes
url https://doi.org/10.1371/journal.pone.0209150
work_keys_str_mv AT serenapavoni smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT rafikajarray smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT feridnassor smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT annececileguyot smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT stevecottin smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT jessicarontard smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT jacquelinemikol smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT aloisemabondzo smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT jeanphilippedeslys smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes
AT frankyates smallmoleculeinductionofab42peptideproductioninhumancerebralorganoidstomodelalzheimersdiseaseassociatedphenotypes